Interferon-gamma-producing T cell (IFN-γ+ T cell) (IFN-γ+ T cell)

Interferon-gamma (IFN-γ)-producing T cells, primarily comprising Th1 CD4+ cells and CD8+ cytotoxic T lymphocytes, are central coordinators of the adaptive immune response against intracellular pathogens and tumors (PMID: 14734551). These cells secrete IFN-γ, a potent pleiotropic cytokine that activates macrophages, enhances antigen presentation via MHC class I and II induction, and promotes the differentiation of more Th1 cells (PMID: 29780381). In oncology, the presence and activity of these cells within the tumor microenvironment are strongly associated with positive prognosis and responsiveness to immune checkpoint inhibitors like PD-1 and CTLA-4 blockers (PMID: 32190368). Conversely, dysregulated or chronic activation of IFN-γ-producing T cells is a hallmark of various autoimmune and inflammatory conditions, such as rheumatoid arthritis and multiple sclerosis (PMID: 30217907). Therapeutic strategies involve either boosting their activity to combat cancer and infections or suppressing them to treat inflammatory disorders. Monitoring these cells via biomarkers like T-bet expression or IFN-γ secretion levels is critical for assessing treatment efficacy in modern immunotherapy.

Other names

Th1 cellType 1 helper T cellIFN-gamma secreting T lymphocyteEffector T cellCytotoxic T lymphocyteIFN-gamma+ CD4+ T cellIFN-gamma+ CD8+ T cell

Therapeutic modulation involves the activation and expansion of these cells to enhance antitumor immunity (e.g., via checkpoint inhibition) or their suppression to control inflammatory and autoimmune responses.